# Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED)

> **NCT00230230** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 91 (actual)

## Conditions studied

- Cough

## Interventions

- **DRUG:** SCH 486757

## Key facts

- **NCT ID:** NCT00230230
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2015-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00230230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00230230, "Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00230230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*